Editorial: Translational control in cancer
- PMID: 39045152
- PMCID: PMC11263875
- DOI: 10.1093/narcan/zcae031
Editorial: Translational control in cancer
Similar articles
-
Editorial: The state of the art in head and neck cancer and carcinogenesis translational research.Front Oral Health. 2023 Aug 8;4:1266272. doi: 10.3389/froh.2023.1266272. eCollection 2023. Front Oral Health. 2023. PMID: 37614848 Free PMC article. No abstract available.
-
Editorial: Post-translational modifications of proteins in cancer immunity and immunotherapy.Front Immunol. 2022 Aug 12;13:1006145. doi: 10.3389/fimmu.2022.1006145. eCollection 2022. Front Immunol. 2022. PMID: 36032068 Free PMC article. No abstract available.
-
Editorial: Community series in post-translational modifications of proteins in cancer immunity and immunotherapy, volume II.Front Immunol. 2023 Sep 26;14:1289016. doi: 10.3389/fimmu.2023.1289016. eCollection 2023. Front Immunol. 2023. PMID: 37822939 Free PMC article. No abstract available.
-
Editorial: Translational neuroscience and reverse translational neuroscience: What's giving us hope?Front Neurosci. 2023 Feb 22;17:1149819. doi: 10.3389/fnins.2023.1149819. eCollection 2023. Front Neurosci. 2023. PMID: 36908775 Free PMC article. No abstract available.
-
Translational epidemiology: The powerful tool for precision cancer medicine.J Cancer Res Ther. 2019;15(2):269-271. doi: 10.4103/jcrt.JCRT_276_18. J Cancer Res Ther. 2019. PMID: 30964096 Review.
References
Publication types
LinkOut - more resources
Full Text Sources